Official websites use. Share sensitive information only on official, secure websites. The use, distribution or reproduction in other forums is permitted, provided the original author s and the copyright owner s are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. Cross-sectional analyses were conducted using retrospective data obtained from 1, registries.
It included demographic and anthropometric variables, cardiometabolic traits, and HIV-related virological and immunological indices. For descriptive statistics, we used mean values of the quantitative variables from unbalanced visits across 20 months. Robust regression methods were used to determine the associations. In contrast, VACC individuals had increased blood pressure and dyslipidemia. The high burden of T2D in these individuals necessitates rigorously designed longitudinal studies to draw potential causal inferences and develop better treatment regimens.
However, when compared to the general population, PWH have an increased incidence of common age-associated degenerative diseases, including metabolic disorders such as type 2 diabetes T2D and cardiovascular disease CVD. A recent study estimated that the median Latino disparity in the HIV prevalence to be 2. Hispanics also have a higher prevalence of cardiometabolic risk factors that predispose them to T2D when compared to non-Hispanic whites NHW.
For example, Lorenzo et al. They showed that Mexican Americans have an odds ratio of 2. However, few studies have systematically examined the incidence of these metabolic disorders in HIV-infected Hispanics, especially in the U.
Nansseu et al. A similar trend was observed in overweight people who became obese. In another study, Sax et al. This is of great concern as a majority of MAs are overweight or obese with increased genetic susceptibility to T2D and other metabolic diseases and, when infected with HIV, may have a poorer response to T2D medications compared to non-Hispanic whites 7.
